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Abstract
Background: Application of superparamagnetic iron oxide nanoparticles (SPIOs) as the contrast agent
has improved the quality of magnetic resonance (MR) imaging. Low efficiency of loading the commercially
available iron oxide nanoparticles into cells and the cytotoxicity of previously formulated complexes limit
their usage as the image probe. Here, we formulated new cationic lipid nanoparticles containing SPIOs
feasible for in vivo imaging.
Methods: Hydrophobic SPIOs were incorporated into cationic lipid 1,2-dioleoyl-3-(trimethylammonium)
propane (DOTAP) and polyethylene-glycol-2000-1,2-distearyl-3-sn-phosphatidylethanolamine (PEG-
DSPE) based micelles by self-assembly procedure to form lipid-coated SPIOs (L-SPIOs). Trace amount of
Rhodamine-dioleoyl-phosphatidylethanolamine (Rhodamine-DOPE) was added as a fluorescent indicator.
Particle size and zeta potential of L-SPIOs were determined by Dynamic Light Scattering (DLS) and Laser
Doppler Velocimetry (LDV), respectively. HeLa, PC-3 and Neuro-2a cells were tested for loading
efficiency and cytotoxicity of L-SPIOs using fluorescent microscopy, Prussian blue staining and flow
cytometry. L-SPIO-loaded CT-26 cells were tested for in vivo MR imaging.
Results: The novel formulation generates L-SPIOs particle with the average size of 46 nm. We showed
efficient cellular uptake of these L-SPIOs with cationic surface charge into HeLa, PC-3 and Neuro-2a cells.
The L-SPIO-loaded cells exhibited similar growth potential as compared to unloaded cells, and could be
sorted by a magnet stand over ten-day duration. Furthermore, when SPIO-loaded CT-26 tumor cells were
injected into Balb/c mice, the growth status of these tumor cells could be monitored using optical and MR
images.
Conclusion: We have developed a novel cationic lipid-based nanoparticle of SPIOs with high loading
efficiency, low cytotoxicity and long-term imaging signals. The results suggested these newly formulated
non-toxic lipid-coated magnetic nanoparticles as a versatile image probe for cell tracking.
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Background
Developing nanoprobe is important for diversely func-
tional analysis in biomedical research [1]. Utilization of
nanoparticles such as gold nanoparticles, quantum dots
and superparamagnetic iron oxide nanoparticles (SPIOs)
has been a fast growing area in molecular imaging. Nano-
sized gold particles are highly reactive in biological
milieu, whereas quantum dots are nanocrystals of heavy
metals in nature. But both of these nanoparticles are not
biocompatible for human and for clinical practice. In this
respect, SPIOs with polymeric coating, such as dextran,
have been widely used in magnetic resonance (MR) imag-
ing [2]. With its high spatial resolution, it has been widely
used for tracking cell migration [3-5] and monitoring in
vivo status of stem cell differentiation [6-9].
Because of the low efficiency of direct loading of these
commercially available iron oxide nanoparticles into
cells, transfection reagents such as cationic lipids, polyly-
sine and protamine sulfate have been used for non-spe-
cific delivery of iron oxide nanoparticles into cells [10-
13]. However, the formulated complexes are not stable
and tend to aggregate in test tubes or even precipitate in
the cell culture conditions, resulting in cytotoxicity [14].
Therefore, it remains a need to formulate new complexes
without cytotoxicity for improving the delivery efficien-
cies to cells.
Polyethylene glycol (PEG)-modified lipids or polymers
have been widely used to form the nanocarriers for phar-
maceutical applications. Due to its small size, neutral sur-
face charge and high hydrophilicity, PEG-modification
greatly reduces the interactions of nanoparticles with
plasma proteins and cells, ensuring their long circulation
in the blood [15]. Similarly, charged phospholipids
could, by themselves, form self-assembled film or parti-
cles in aqueous solutions. The diacyllipids, such as 1,2-
dioleoyl-3-(trimethylammonium) propane (DOTAP)
with strong positive charge and low transition tempera-
ture, may facilitate the quick formation of nanoparticles
in physiological buffers [16,17]. Accordingly, we devel-
oped a novel formula of nanoparticles by combining
PEG-lipid and DOTAP with SPIOs, and demonstrated the
cellular uptake, biocompatibility and usage in the in vivo
imaging of these new nanoparticles. The advantages of
these new formulated lipid-coated SPIOs (L-SPIOs)
include their small sizes, relative stability in physiological
buffers, suitability for bimodal imaging and high loading
efficiency to cells, allowing their usage as a versatile image
probe for in vivo tracking analysis.
Methods
Materials
1,2-dioleoyl-3-(trimethylammonium) propane
(DOTAP), polyethylene-glycol-2000-1,2-distearyl-3-sn-
phosphatidylethanolamine (PEG-DSPE) and Rhodam-
ine-dioleoyl-phosphatidylethanolamine (Rhodamine-
DOPE) were obtained from Avanti Polar Lipids (Alabas-
ter, AL, USA). These lipids were dissolved in chloroform
individually, sealed in ampoules filled with argon gas and
stored at -20°C before use. Dulbecco's Modified Eagle's
Medium (DMEM) and RPMI-1640 medium were pur-
chased from GIBCO™ Invitrogen Corporation (Grand
Island, NY, USA). Other chemicals were purchased from
Sigma-Aldrich (St. Louis, MO, USA).
Cell cultures
Human cervical cancer cells (HeLa), human prostatic ade-
nocarcinoma cell lines (PC-3), mouse neuroblastoma
cells (Neuro-2a) and mouse colorectal adenocarcinoma
cells (CT-26) were obtained from the American Type Cul-
ture Collections (ATCC) (MD, USA). HeLa, PC-3 and
Neuro-2a cells were cultured in DMEM supplemented
with 10% heat-inactivated fetal bovine serum (10% FBS-
DMEM), whereas CT-26 cells were cultured in RPMI-1640
medium plus 10% serum. Routine cell culture was carried
out at 37°C with supplementation of 5% CO2.
Synthesis of hydrophobic SPIO nanoparticles
The hydrophobic SPIOs with size of 10 nm were synthe-
sized using a seed-growth method by reducing Fe(acac)3
with 1,2-dodecanediol and protected by oleic acid and
oleylamine in benzyl ether. After mixing in a round bot-
tom flask and followed by heating to reflux (300°C)
under nitrogen atmosphere for 1 h, the SPIOs were precip-
itated by adding ethanol, collected by centrifugation and
dissolved in hexane in the presence of oleic acid and
oleylamine. For lipid coating, the nanoparticles were pre-
cipitated and resuspended in chloroform before use.
Preparation of lipid-coated SPIOs
Lipid-coated SPIOs (L-SPIOs) were prepared using a com-
bination of the standard thin-film hydration method [18]
and sonication process. Briefly, DOTAP and PEG-DSPE at
3:1 molar ratio in chloroform were mixed with hydropho-
bic SPIOs and trace amount of Rhodamine-DOPE, and
then evaporated under reduced pressure. The resulted
SPIO-lipid film was hydrated in distilled water to give the
final concentrations of cationic lipids at 200 μM and iron
oxide at 375 μg/ml. The solution of L-SPIOs was inten-
sively sonicated at 60°C for 20 min. They were then sorted
by the magnet, filter-sterilized through a Millex 0.22-μm-
diameter filter and stored at 4°C in argon gas before use.
Size and zeta potential determinations of lipid-coated 
SPIOs
The diameters and zeta potential of L-SPIOs were deter-
mined using a Zetasizer Nano-ZS90 (Malvern Instruments
ZEN3590, Worcs, UK). The size was analyzed by Dynamic
Light Scattering (DLS), and the zeta potential was calcu-Journal of Biomedical Science 2009, 16:86 http://www.jbiomedsci.com/content/16/1/86
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lated by Laser Doppler Velocimetry (LDV) at 25°C with
samples suspended in de-ionized water. Prior to use, all
glass and plastic wares were pre-washed with filtered
water to minimize particulate contamination.
Cellular loading of lipid-coated SPIOs
HeLa, PC-3 and Neuro-2a cells were seeded individually
in each well of the 24-well plates (2-5 × 104 cells/well)
overnight before L-SPIOs loading. Trace amount of Rhod-
amine-DOPE in the L-SPIOs was an indicator for moni-
toring the translocation of nanoparticles. After incubating
with L-SPIOs (1-2 nmole/well, equivalent 1.875-3.75 μg
SPIO) at different time points with or without the appli-
cation of magnetic field, cells were washed with PBS. The
high resolution fluorescent images were recorded using a
fluorescent microscope (Leica DM IRB with the halogen
lamp).
Prussian blue staining
HeLa cells were seeded in a 24-well plate (5 × 104/well)
overnight and treated with L-SPIOs (1 nmole/well) for 2
h, with or without magnetic field. These cells were then
washed three times with PBS and fixed in 4% formalde-
hyde solution for 30 min. After fixation, the cells were
stained for the presence of intracellular iron with fresh
prepared potassium ferrocyanate solution (mixture of
equal volume of 4% potassium ferrocyanate with 4%
hydrochloric acid) for 30 min. After wash three times with
distilled water, the cells were then counterstained with
Nuclear Fast Red Counterstain (Sigma-Aldrich) at room
temperature for 5 min.
Flow cytometry analysis of L-SPIO-loaded cells
Cells loaded with L-SPIOs were washed with PBS and
trypsinized. Their cell loading efficiency was evaluated by
scoring the percentage of Rhodamine fluorescent-positive
cells using a FACS Calibur System (Becton-Dickinson, San
Jose, CA, USA). The experiments were performed in tripli-
cate, and 10,000 cells were counted in each experiment.
Long-term growth and magnetic properties of L-SPIO-
loaded cells
HeLa and PC-3 Cells were seeded in a 24-well plate (5 ×
104/well) overnight and treated with L-SPIOs (1 nmole/
well) for 12 h. These cells were then washed with PBS
twice and trypsinized. To analyze the effects of L-SPIO-
loading on cell growth, both L-SPIO-loaded and control
cells (1.5 × 105/100-mm dish) were cultured for more
than 10 days and cell numbers were counted at different
time points by the hemocytometer. To determine the
magnetic property of L-SPIO-loaded cells, cells were
trypsinized at different time points and equal amount of
cells (5 × 105/500-μl medium in an Eppendorf tube) were
sorted by the magnet stands and the magnet-bound cells
were counted with a hemocytometer.
Induction and assessment of neuron cell differentiation
For morphological differentiation analysis, the degree of
neurite outgrowth was assessed by phase-contrast micros-
copy [19,20]. Briefly, Neuro-2a cells were treated with 5
mM retinoic acid in 1% FBS-containing medium for 60 h.
The neurite-like processes longer than the major cell body
diameter were defined as differentiated cells. In each well,
two hundred cells in three random fields were counted.
Data were expressed as percentage of neurite-bearing cells
in total cell population.
Imaging of tumor growth
For MR imaging of tumor growth, CT-26 cells (1 × 106)
were seeded in 100-mm dish overnight before L-SPIOs
loading (20 nmole lipid/dish, equivalent to 37.5 μg SPIO
per dish). After 16 h, CT-26 cells were removed and resus-
pended in PBS. Control and L-SPIO-loaded CT-26 cells (3
× 106, respectively) were injected into the dermis tissue of
Balb/c mice to initiate tumors. After 2 and 15 days, MR
imaging were taken from the anesthetized animals. These
experimental protocols were approved by National Tai-
wan University Institutional Animal Care and Use Com-
mittee. For MRI scanning of anesthetized animals, a 3T
MR system (Biospec; Bruker, Ettlingen, Germany) was
used. T2-weighted images were obtained by fast spin echo
sequence, TR/TE of 3500/62 ms, sliced thickness = 1 mm,
field of view = 40 × 20 mm2, matrix size = 256 × 256 and
NEX = 5. The total scanning time was 4 min. T2*-weighted
images were obtained by gradient echo sequence, TR/TE =
250/7 ms, sliced thickness = 1 mm, field of view = 40 × 20
mm2, matrix size = 256 × 256 and NEX = 10. The total
scanning time was 8 min. After scanning at 15th day, the
tumor nodules were excised, fixed in formalin, embedded
in paraffin, and processed into 5-μm sections. They were
then stained with haematoxylin and eosin (H&E) follow-
ing the standard histological protocol.
Results
Characterization of lipid-coated SPIOs
In pharmaceutical research, PEG-modified lipids have
been widely used to form nanoparticles or micelles for
drug targeting. Combined with a cationic lipid 1,2-diole-
oyl-3-(trimethylammonium) propane (DOTAP), it could
form a stable and uniform nanocarrier to encapsulate
hydrophobic superparamagnetic iron oxide nanoparticles
(SPIOs). The average size of these formulated lipid-coated
SPIOs (L-SPIOs) was about 46 nm in diameter as shown
in Fig 1A, carrying a positive zeta potential in deionized
water (49.5 ± 0.8 mV). Incorporation of trace amount
(less than 0.1%) of Rhodamine-DOPE as a fluorescent
indicator did not affect the particle size. These L-SPIOs
remained stable in a small and uniform size in distilled
water or 5% glucose solution for more than three months.
Culture medium, with or without serum, did not influ-Journal of Biomedical Science 2009, 16:86 http://www.jbiomedsci.com/content/16/1/86
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Figure 1 (see legend on next page)
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ence the size of L-SPIOs after magnetic sorting. (data not
shown).
Magnetic effect on the delivery of lipid-coated SPIOs into 
cultured cells
To facilitate the delivery of L-SPIOs into cells, a magnet
apparatus was used in cell culture condition. HeLa cells
(2-5 × 104/well) were seeded and treated with 1 nmole/
well L-SPIOs in 10% FBS-DMEM with or without the
application of magnetic field. Trace amount of Rhodam-
ine-DOPE was used as an indicator for localizing these
nanoparticles. As shown in Figure 1 (Fig. 1B), the presence
of magnetic field for 2 h remarkably improved the loading
of L-SPIOs in HeLa cells without disrupting cell morphol-
ogy. The magnetic field facilitated a time-dependent sedi-
mentation and translocation of L-SPIOs into cells (Fig. 1C
and 1D). The loading efficiency with magnet for 2 h was
almost equal to that without magnet for 12 h. The loaded
nanoparticles were mostly located in the cytoplasm as
shown in the confocal microscopy, with only negligible L-
SPIOs remaining bound to the cell membrane after 16 h
of the nanoparticle treatment (Fig. 1E).
Long-term viability and magnetic properties of L-SPIO-
loaded cells
After lipid coating, L-SPIOs retained the magnetic proper-
ties of SPIOs indicated on the magnet stand (Fig. 2A, left).
When cationic surface-charged L-SPIOs were introduced
into HeLa cells with the assistance of magnetic field gradi-
ent for 12 h, the cells demonstrated similar magnetic
properties as L-SPIOs on magnet stand (Fig. 2A, right).
Cell proliferation assay was used to determine whether L-
SPIOs affected cell viability. After seeding cells in culture
plates, the cell number of control and L-SPIO-loaded cells
were counted using the hemocytometer in different day.
As shown in Figure 2B, there was no effect of L-SPIO load-
ing on cell growth up to 11 days. HeLa and PC-3 cells were
loaded with L-SPIOs to further assess the duration of mag-
netic property of the L-SPIO-loaded cells (Fig. 2C). After
loading L-SPIOs at different time points, the SPIO-posi-
tive cells were separated by a magnet stand and counted
with a hemocytometer. More than 80% of the SPIO-
loaded cells still preserved the magnetic property when
cultured for 7 days (Fig. 2C).
Effects of L-SPIO-loading on neuronal cell differentiation
We next evaluated the biocompatibility by testing the
effect of L-SPIO-loading on neuronal cell differentiation.
To this end, Neuro-2a cells, an albino mouse neuroblast-
oma cell, were treated with L-SPIOs (4 nmole lipid/well,
equivalent to 7.5 μg SPIO per well) for 24 h. Following the
SPIO-loading, Neuro-2a cells were treated with 5 μM of
retinoic acid for another 60 h to induce neuronal differen-
tiation. Figure 3 showed that neuronal differentiation was
evident in both control and L-SPIO-loaded Neuro-2a cells
with no significant difference in morphological differenti-
ation between control and L-SPIO- loaded Neuro-2a cells
(control: 86.5 ± 4.3%; L-SPIO-loaded: 82.7 ± 7.4%).
In vivo study of tumor cell growth by optical and MR 
imaging
To further know whether the SPIO-loaded cells were suit-
able for in vivo study, control or SPIO-loaded CT-26 cells
(3 × 106) were injected subcutaneously into the back of
Balb/c mice followed by MR imaging at Day 2 and Day 15
after tumor cell inoculation by a clinical 3T MR system.
The  T2-weighted and T2*-weighted MR images were
obtained as described in Methods (Fig. 4). In control cells
(images A, C and E), tumor proliferation was obvious in
both T2-weighted (image A) and T2*-weighted (image C)
MR images at Day 2, and tumor size increased remarkably
to 5 mm in diameter at Day 15 (image E). When the Balb/
c mice were injected with L-SPIO-loaded cells, the T2-
weighted (image B) and T2*-weighted (image D) images
both revealed cell growth at Day 2. Tumor grew to a com-
parable size as compared to control cell inoculation at
Day 15. In order to determine cell viability of the central
region (2.5 mm in diameter) of tumor, which are positive
in MRI signal as indicated by arrow in Fig. 4F, histological
staining and examination were employed. Tissue sections
showed that the subcutaneous tumor was a poorly differ-
entiated carcinoma, consisting of mostly viable tumor in
both the center and peripheral regions of the tumor (Fig.
5). The histological examination also showed no differ-
Magnet effect on L-SPIOs loading in HeLa cells Figure 1 (see previous page)
Magnet effect on L-SPIOs loading in HeLa cells. (A) Size distribution of L-SPIOs particles. (B) Images of HeLa cells 
treated with 1 nmole/well of L-SPIOs for 2 h in 10% FBS-DMEM with magnet (right panel) or without magnet (left panel). Trace 
amount of Rhodamine-DOPE was used as an indicator for localizing the position of the nanoparticles. Images were taken after 
L-SPIO treatment (phase and fluorescent images: 100× magnification; Prussian blue staining: 400× magnification). (C) Time-
dependent effect of magnet on cell loading. HeLa cells were seeded overnight and treated with 1 nmole/well of L-SPIOs for 0, 
0.5, 1 and 2 h. These fluorescent images were taken at different time points as indicated on the right. (D) Flowcytometric anal-
ysis of cells from (C) was shown. (E) Confocal image of L-SPIO-loaded HeLa cells. HeLa cells treated with L-SPIOs (1 nmole/
well) for 16 h. After washed with cold PBS, cells were fixed and analyzed by a confocal microscope. Red fluorescence in cells 
was indicated as L-SPIOs, whereas blue fluorescence was nucleus. Scale bar = 40 μm. Data represent three independent exper-
iments with similar results.Journal of Biomedical Science 2009, 16:86 http://www.jbiomedsci.com/content/16/1/86
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ence between tumors formed by control and L-SPIO-
loaded CT-26 cancer cells (data not shown). These results
demonstrated that CT-26 cells loaded with L-SPIOs
retained the magnetic property for in vivo MR studies up
to 15 days. The tumor growth was not affected by L-SPIOs
and the MR images were readily distinguishable from
those of control cells, thus allowing for a long-term track-
ing.
Discussion
Nanotechnology provides size-controlled nanostructures
such as quantum dots and magnetic iron oxide nanopar-
ticles for molecular imaging [21]. For cellular MR imag-
ing, nonspecific labeling of primary cells and stem cells
with these nanoparticles has been used in biomedical
research. From technical aspect, loading iron oxide nano-
particles with transfection reagents such as liposomes,
polylysine and protamine sulfate from the market is
achievable [10-14]. But the sizes of these complexes in the
present of serum are greater than 150 nm or even up to 1
μm in diameter, thus limiting their use in targeted delivery
and live cell imaging [22-25]. In this study, we have devel-
oped a novel formulation of functionalized SPIOs by
encapsulating of SPIOs into diacyllipid formed- micelles
composing of DOTAP and PEG-DSPE. This strategy
resulted in small and stable cationic nanoparticles with
magnetic iron oxide in the core, allowing an efficient cel-
lular loading with low cytotoxicity for in vivo imaging.
PEG-lipid, due to its high water solubility and low toxic-
ity, is self-assembled into nanosized micelles for drug
delivery [16]. But, the long chain of PEG blocks lower the
uptake of micelles by the reticuloendothelial system,
thereby resulting in the long circulation times in blood
[26]. In this regard, cationic lipids also increase solubility
of the nanoparticles in the physiological buffers while is
capable of loading nanoparticles into cells, presumably
via the negatively charged biomolecules on cell mem-
brane. With low transition temperature and low toxicity,
DOTAP has been demonstrated to be an effective cationic
lipid for transfection [27-29]. In our new formulation, we
circumvent the disadvantage of PEG in prohibiting parti-
cle cellular uptake by including DOTAP to overcome the
PEG shielding effect, thus facilitating nanoparticle trans-
location across cell membrane.
Figure 2
Magnet effect on L-SPIOs and L-SPIO-loaded cancer cells Figure 2
Magnet effect on L-SPIOs and L-SPIO-loaded cancer 
cells. (A) L-SPIOs in water were placed on the magnetic 
stand (left); HeLa cells treated with L-SPIOs (1 nmole/ml) for 
12 h were on the right. Arrows indicate the position of L-
SPIO nanoparticles or the L-SPIO-loaded cells. (B) Long-term 
viability of L-SPIO-loaded cells. HeLa cells were first seeded 
in a 24-well plate (5 × 104/well) overnight and treated with 1 
nmole/well of L-SPIOs for 12 h in 10% FBS-DMEM. After dif-
ferent time periods of culture, cells were washed, trypsinized 
and counted with a hemocytometer. (C) Magnetic properties 
of L-SPIO-loaded cells. HeLa and PC-3 cells were treated 
with the above L-SPIOs for 12 h in 10% FBS-DMEM and har-
vested at different time points. L-SPIO-positive cells were 
separated by a magnet stand and counted with a hemocytom-
eter. All experiments were performed in triplicate. Results 
are mean ± SEM (n = 3).Journal of Biomedical Science 2009, 16:86 http://www.jbiomedsci.com/content/16/1/86
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Another interesting feature in our formulation is that
application of magnetic field in nanoparticle-loading
resulted in significant increase of cellular uptake in a dose-
and time-dependent manner (Fig 1). Of note, when ini-
tially loaded with high amount of magnetic nanoparticles,
more than 80% of HeLa or PC-3 cells could maintain
magnetic property up to 7 days, indicating the long reten-
tion of iron oxide (Fig 2). The loaded nanoparticles were
predominately located in the cytoplasm rather than on
the cell membrane of these cells (Fig 1D). In our previous
experiments using lipid-enclosed quantum dots (LEQD)
[30], the durations of internalized LEQD could be
detected by third harmonic generation (THG) microscopy
in these loaded cells for more than two weeks. Since only
lipid-coated quantum dots but not bare quantum dots
could generate strong THG signal, we inferred here that
the SPIOs inside cells may be still in lipid-coated form
within time of these experiments. Further, it should be
mentioned that magnet-assisted gene delivery has been
shown to increase the efficiency of pDNA transfection but
with a significant increase of cellular toxicity in human
umbilical vein endothelial cell (HUVEC) [31]. In addi-
tion, long term expose of anionic iron oxide (Fe2O3) nan-
oparticles, at concentration range from 150 μM to 15 mM,
caused PC12M cytotoxicity in both cell growth and neur-
ites outgrowth [32]. Given the negligible cytotoxicity of L-
SPIOs loading at high concentration both in cancer cell
growth (HeLa, PC-3) and neural cell differentiation
(Neuro 2a) (Fig 2B and 3), L-SPIOs thus have a potential
in efficient drug delivery with low cytotoxicity and long
duration.
Iron oxide nanoparticles were widely used in labeling cells
due to their ability to create apparent image upon cellular
internalization and particle clustering [33]. In vitro labe-
ling of lymphocytes, such as T-cells and dendritic cells,
and their tracking in vivo after injection into mice can be
also visualized their pathogenesis and evolution using
clinical MRI [34]. It also demonstrated that implantation
of iron-oxide-labeled transplanted cells can be monitored
within individual animals for a prolonged time by MR
imaging [6,35]. Therefore, it is feasible to monitor the
prelabeled stem cells with iron oxide in differentiation
and visualize the presence and migration of transplanted
stem cells to the cerebral ischemia [36,37]. Nevertheless,
it was believed that the intracellular concentration of
SPIOs decreased when cell proliferated, hence reducing
the MRI signals for long-term in vivo tracking. However,
results from our in vivo study of tumor growth (Fig 4)
clearly demonstrated that even after 15 days the MRI sig-
nals were still detectable. Histological data showed that
the tumor mass formed from injected L-SPIO-loaded
Differentiation status of Neuro-2a Figure 3
Differentiation status of Neuro-2a. Neuro-2a cells were treated with or without L-SPIOs (4 nmol/well) for 24 h in 10% 
FBS-DMEM. After L-SPIO-loading, Neuro-2a cells were then washed and exposed to 5 μM of retinoic acid for differentiation 
indicated by neurites outgrowth. Phase Images of Neuro-2a cells before (A, B; 100× magnification) and after (C, D; 200× mag-
nification) retinoic acid (RA) treatment in control or L-SPIO-loaded cells as indicated.
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tumor cells were viable both the center and peripheral
regions (Fig. 5), with similar growth potential as com-
pared to non-SPIO-loaded cells (Fig. 4E, 4F). This is con-
sistent with a recent report by Nelson et.al. showing that a
long duration imaging of SPIO-loaded cells in SCID mice
[38]. Thus, the biocompatibility nature of L-SPIO nano-
particles supports their use for long-term cell tracking and
imaging in the in vivo system.
Conclusion
We have developed a novel cationic lipid-based nanopar-
ticle of SPIOs with high loading efficiency, low cytotoxic-
ity and long-term imaging signals. The potential of our
lipid-coated magnetic nanoparticles is at least three folds.
First, the iron oxide moiety helps the magnet-enhanced
nanoparticle delivery and MR imaging, as well as for
potential hyperthermia therapy. Second, targeted proper-
ties can be achieved by adding targeted ligands onto PEG
MR imaging of L-SPIO-loaded cancer cells Figure 4
MR imaging of L-SPIO-loaded cancer cells. L-SPIO loaded CT-26 cells were injected into the dermis of Balb/c mice. MRI 
imaging was performed in these mice bearing orthotopic colorectal tumor (triangle) 2 days (A~D) and 15 days (E, F) after sub-
cutaneous injection of control and L-SPIO-loaded CT-26 cells. T2-weighted images of tumor nodule from CT-26 cells without 
(A) and with L-SPIOs (B) were shown. T2*-weighted images of tumor nodule from CT-26 cells without (C, E) and with L-SPIOs 
(D, F) were shown.
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linker of the lipid shell. Third, it provides size-controlled
nanostructures that integrate biomolecules onto their
lipid coat for efficient drug delivery. We believe that this
multifunctional nanoparticle will provide an efficient way
for in-vivo cell tracking [30], and therefore make a poten-
tial contribution to nanomedicine research in the future.
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